Inicio › Leucemia bifenotípica aguda › California

Ensayos clínicos de Leucemia bifenotípica aguda en California

15 estudios sobre Leucemia bifenotípica aguda buscan participantes en California.

Ciudades en California

Texto oficial del estudio (inglés)

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Loma Linda University Medical Center, Loma Linda
Miller Children's and Women's Hospital Long Beach, Long Beach
UCSF Benioff Children's Hospital Oakland, Oakland
y 4 más

ReclutandoFase 2

365 Days · Todos los sexos · Actualizado el 27 oct 2026 · NCT06317662

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

City of Hope, Duarte
Valkyrie Clinical Trials, Los Angeles

ReclutandoFase 1/2

Edades de 13 a 90 · Todos los sexos · Actualizado el 26 oct 2026 · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Rady Children's Hospital, San Diego

ReclutandoFase 1

Edades de 1 a 30 · Todos los sexos · Actualizado el 22 oct 2026 · NCT06177067

A Study of Revumenib and Mezigdomide in People With Leukemia

City of Hope Cancer Center (Data collection only), Duarte

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 20 oct 2026 · NCT07356154

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

City of Hope Medical Center, Duarte

ReclutandoFase 1

Edades de 2 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06575296

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

City of Hope, Duarte
UC Davis, Sacramento
Stanford Health Care, Stanford

ReclutandoFase 1

Edades de 12 a 78 · Todos los sexos · Actualizado el 29 sept 2026 · NCT03802695

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Kaiser Permanente Downey Medical Center, Downey
City of Hope Comprehensive Cancer Center, Duarte
Loma Linda University Medical Center, Loma Linda
y 14 más

ReclutandoFase 3

365 Days – 25 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Kaiser Permanente Downey Medical Center, Downey
Loma Linda University Medical Center, Loma Linda
Miller Children's and Women's Hospital Long Beach, Long Beach
y 8 más

ReclutandoFase 1/2

Hasta los 22 · Todos los sexos · Actualizado el 25 ago 2026 · NCT04726241

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

Rady Children's Hospital, San Diego

ReclutandoFase 2

Edades de 1 a 18 · Todos los sexos · Actualizado el 10 ago 2026 · NCT06390319

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Rady Children's Hospital, San Diego

ReclutandoFase 4

Edades de 1 a 18 · Todos los sexos · Actualizado el 14 jul 2026 · NCT06289673

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

UCLA Department of Medicine, Los Angeles

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07216443

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Stanford University, Palo Alto

ReclutandoFase 1

Edades de 18 a 70 · Todos los sexos · Actualizado el 23 jun 2026 · NCT06551584

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

City of Hope, Duarte
Los Angeles Cancer Network, Los Angeles
UCLA Medical Center of Hematology/Oncology, Los Angeles
y 1 más

ReclutandoFase 1/2

Edades de 12 a 95 · Todos los sexos · Actualizado el 15 abr 2026 · NCT04329728

Venetoclax Basket Trial for High Risk Hematologic Malignancies

University of California San Francisco-Benioff Children's Hospital, San Francisco

ReclutandoFase 1

Edades de 1 a 40 · Todos los sexos · Actualizado el 12 mar 2026 · NCT05292664

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Children's Hospital Los Angeles, Los Angeles
Children's Hospital Orange County, Orange
UCSF School of Medicine, San Francisco

ReclutandoFase 1

Edades de 1 a 21 · Todos los sexos · Actualizado el 6 dic 2024 · NCT05476770

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.